Joseph Rogers

Author PubWeight™ 88.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 2007 7.23
2 GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007 6.88
3 The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank 2008 4.13
4 Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging 2011 3.83
5 Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging 2003 2.96
6 The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013 2.71
7 The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010 2.59
8 Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 2008 2.59
9 Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2012 2.36
10 Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 2008 2.29
11 Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics 2008 2.11
12 Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 2005 1.99
13 Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007 1.98
14 Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics 2006 1.88
15 Dispatcher-assisted cardiopulmonary resuscitation: risks for patients not in cardiac arrest. Circulation 2009 1.71
16 Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial. Am Heart J 2011 1.65
17 Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging 2008 1.60
18 Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 2006 1.58
19 Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 2012 1.57
20 Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010 1.57
21 Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 2009 1.49
22 Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. J Am Coll Cardiol 2013 1.34
23 Sorl1 as an Alzheimer's disease predisposition gene? Neurodegener Dis 2007 1.31
24 Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant 2013 1.27
25 Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron 2013 1.26
26 Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol Aging 2005 1.24
27 Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. Psychosom Med 2013 1.24
28 Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging 2008 1.24
29 CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease. Neurobiol Aging 2004 1.19
30 Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy. Circulation 2006 1.18
31 Principal strain orientation in the normal human left ventricle. Ann Thorac Surg 2005 1.14
32 Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg 2010 1.11
33 Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol Aging 2012 1.10
34 Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. J Neuroimmunol 2002 1.04
35 Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem 2002 1.02
36 Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol Aging 2008 1.00
37 Magnetic resonance imaging-based multiparametric systolic strain analysis and regional contractile heterogeneity in patients with dilated cardiomyopathy. J Heart Lung Transplant 2009 0.99
38 Cost of ventricular assist devices: can we afford the progress? Circulation 2013 0.99
39 High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation. BMC Genomics 2010 0.95
40 Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease. J Comp Neurol 2009 0.94
41 Quantification of cytokines involved in wound healing using surface plasmon resonance. Anal Chem 2005 0.93
42 Amiodarone and bepridil inhibit anthrax toxin entry into host cells. Antimicrob Agents Chemother 2007 0.88
43 Molecular and cellular mediators of Alzheimer's disease inflammation. J Alzheimers Dis 2001 0.88
44 Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer's disease pathophysiology. PLoS One 2013 0.87
45 Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease. Arch Neurol 2011 0.86
46 Microglial responses to dopamine in a cell culture model of Parkinson's disease. Neurobiol Aging 2008 0.85
47 Microglial responses to amyloid beta peptide opsonization and indomethacin treatment. J Neuroinflammation 2005 0.85
48 Revascularization for heart failure. Am Heart J 2007 0.81
49 Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. Int J Mol Epidemiol Genet 2009 0.81
50 Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease. Neurosci Lett 2009 0.80
51 Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. Am J Cardiol 2004 0.78
52 Combined X-ray diffraction and kinetic depth effect imaging. Opt Express 2011 0.77
53 Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. J Heart Lung Transplant 2005 0.77
54 Organ cross talk in the critically ill: the heart and kidney. Blood Purif 2009 0.77
55 Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circ Heart Fail 2012 0.76
56 Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients. J Heart Lung Transplant 2012 0.76
57 Interactions of stroke, nonsteroidal anti-inflammatory drugs, and APOE status in dementia risk. Neurology 2008 0.75
58 Position determination of scatter signatures--a novel sensor geometry. Talanta 2010 0.75
59 Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant 2012 0.75
60 The separation of X-ray diffraction patterns for threat detection. Appl Radiat Isot 2009 0.75
61 Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Ann Thorac Surg 2012 0.75
62 Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Circ Heart Fail 2012 0.75
63 Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Ann Thorac Surg 2012 0.75